Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 49 (NPM1P49) is a processed pseudogene of the NPM1 gene. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they are usually not translated into protein and do not have a recognized biological or disease role. While some pseudogenes may act through non-coding RNA or as microRNA decoys in rare instances, there is currently no documented function, disease association, or drug interaction for NPM1P49 specifically. The functional, disease, and therapeutic relevance pertains to the parent NPM1 gene, which encodes a multifunctional nucleolar phosphoprotein involved in ribosome biogenesis, apoptosis, chromatin remodeling, and is implicated in cancer, but these roles do not extend to NPM1P49. Pseudogenes like NPM1P49 are often included in gene databases for annotation but are generally not studied as protein-coding genes, receptors, or drug targets. Nucleophosmin 1 (NPM1), in contrast, is an important cellular protein implicated in various cellular processes and malignancies, particularly acute myeloid leukemia. However, variations and disease roles for NPM1 do not apply to its pseudogenes without specific evidence. The term "receptor" is not appropriate for NPM1P49 or for nucleophosmin pseudogenes. NPM1P49 is a non-functional pseudogene with no established role as a molecular target, biomarker, or disease factor. If a therapeutic or research context incorrectly identifies NPM1P49 as a target, this should be corrected to refer to the parent functional gene, Nucleophosmin 1 (NPM1).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 49 (NPM1P49).